Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN111454217A details a green Rh-catalyzed route for Avapritinib intermediates, offering safer chiral induction and scalable manufacturing for global supply chains.
Patent CN108250049A reveals magnetic ionic liquid catalyst for bisphenol fluorene. Offers high purity, mild conditions, and supply chain stability for polymer manufacturers seeking reliable intermediates.
Patent CN102126969A reveals a breakthrough configuration conversion method for Toremifene, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108484500B reveals a mild iridium-catalyzed route for 1-trifluoroethyl isoquinoline intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN118406018A reveals a breakthrough chiral oxazoline ligand enabling efficient electrochemical dienylation with superior stereoselectivity and scalable manufacturing potential.
Patent CN117603023A reveals metal-free deuteration. Enhances purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN104342463B reveals high-purity biocatalytic route. Enhances supply chain reliability and reduces manufacturing costs for gabapentin intermediates significantly for global buyers.
Patent CN120965623A reveals a green organic catalytic route for 2-functionalized-2,5-dihydrofurans. Achieve high purity and cost reduction in fine chemical manufacturing with scalable methods.
Patent CN110642843A details a novel Pd-catalyzed asymmetric [3+2] cyclization for chiral isonucleosides, offering high enantioselectivity and streamlined supply chains for API manufacturing.
Patent CN110642843A reveals a novel Pd-catalyzed asymmetric [3+2] cyclization for high-purity chiral isonucleosides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112852769A reveals a high-yield enzymatic route for (S)-1-(2-methoxy-3-bromophenyl) ethanol. Discover cost-effective, green manufacturing solutions for this critical API intermediate.
Patent CN113292417A details a green oxidative cleavage process using recyclable Anderson-type catalysts, offering reliable carboxylic acid suppliers a route for cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104593463A reveals enzymatic route for high-purity sweetener intermediates with reduced waste and scalable production capabilities.
Patent CN102787147B reveals enzymatic synthesis for L-dihydroorotic acid. Offers high purity, simplified separation, and scalable production for pharmaceutical intermediates.
Patent CN118028274A details a novel acylase mutant enhancing (S)-o-chlorophenylglycine synthesis. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107903227B reveals a biocatalytic route for high-purity succinic anhydride derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN119432825A reveals immobilized cell catalysis for lauroyl glycine. Enhances stability and reduces costs for personal care chemical manufacturing supply chains.
Patent CN109748929A reveals high-yield synthesis for boronic acid derivatives. Enables cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN108912062B reveals a high-yield catalytic oxidation route for triazolethione derivatives, offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN1940079A details a novel baker's yeast reduction for synthesizing (2S,3S)-2-benzoyl aminomethyl-3-hydroxy-butyrate, a critical 4-AA precursor, offering mild conditions and high optical purity.